Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma

22Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the present study, we investigated the expression of Mcl-1 and Bcl-2 by immunohistochemistry in 85 patients of grades 1-3 and transformed follicular lymphoma (FL). In lymphoma tissue, centroblasts uniformly expressed high levels of Mcl-1 (Mcl-1hi) whereas centrocytes demonstrated low Mcl-1 expression (Mcl-1lo). Bcl-2 expression in centroblasts/centrocytes was reciprocal to Mcl-1 staining in most cases. A high number of Mcl-1 hi centroblasts in tissue sections (≥200/high-power field) correlated with poor overall survival (P < 0·001), independent of the International Prognostic Index and FL grade. This suggests that the number of centroblasts with strong Mcl-1 staining is associated with clinical outcome in FL patients. © 2006 Blackwell Publishing Ltd.

Author supplied keywords

Cite

CITATION STYLE

APA

Michels, J., Foria, V., Mead, B., Jackson, G., Mullee, M., Johnson, P. W. M., & Packham, G. (2006). Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma. British Journal of Haematology, 132(6), 743–746. https://doi.org/10.1111/j.1365-2141.2005.05954.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free